Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-06 · accession 0001415889-24-012466 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-07 | 2024-05-06 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $163.30 | +32.2K | 34.8K | +1,250% | +$5.26M |
| D | 2024-05-07 | 2024-05-06 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $260.51 | -32.2K | 2,577 | -93% | -$8.39M |
| D | 2024-05-07 | 2024-05-06 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $0.00 | -32.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-06 | M | A | 32,200 | $163.30 | 34,777 | D | — | — | (F2) Includes 118, 113, and 111 shares of common stock acquired on March 4, 2022, March 3, 2023, March 4, 2024, respectively, under the United Therapeutics Corporation Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-05-06 | D | D | 32,200 | $260.51 | 2,577 | D | — | — | |
| 3 | Derivative | Share Tracking Award | 2024-05-06 | M | D | 32,200 | $0.00 | 0 | D | $163.30 · 2016-03-13 to 2025-03-13 | 32,200 Common Stock |